10 Best Articles on Drugs
The most useful articles on drugs from around the web—beginners to advanced—curated by thought leaders and our community. We focus on timeless pieces and update the list whenever we discover new, must-read articles or videos—make sure to bookmark and revisit this page.
Top 5 Drugs Articles
At a glance: these are the articles that have been most read, shared, and saved on drugs by Refind users in 2023 so far.
- The High-Stakes Race to Engineer New Psychedelic Drugs
- Young people are using drugs as escapism more than ever before
- Is the World Ready for Extremely Effective Weight-Loss Drugs?
- Biotech labs are using AI inspired by DALL-E to invent new drugs
- First, do no harm: An argument for a radical new paradigm for treating addiction
Watch a video to get a quick overview.
Why Microdosing Is A Scam
Taking small amounts of mushrooms, LSD or MDMA is on the rise, but new science says it MAY BE A SCAM!? If so, why are so many people falling for it. The scie...
Short on time? Check out these useful short articles on drugs—all under 10 minutes.
Young people are using drugs as escapism more than ever before
A new report suggests the kids aren't alright.
Biotech labs are using AI inspired by DALL-E to invent new drugs
Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature.
Is the World Ready for Extremely Effective Weight-Loss Drugs?
A new class of medicines has the potential to permanently change the way we think about obesity.
The growing market for weight loss drugs
A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.
What You Need to Know About Ozempic, the Diabetes Drug Fueling Hollywood’s Harmful Weight-Loss Obsession
As the buzz builds around Ozempic, here’s what you need to know about what it is, how it works, and who should—and, perhaps more importantly, shouldn’t—be taking it.
These are some of the most-read long-form articles on drugs.
The High-Stakes Race to Engineer New Psychedelic Drugs
As psychedelic therapies for mental health go mainstream, companies are recruiting chemists to create patentable versions of hallucinogens. Critics say it’s all a bad trip.
First, do no harm: An argument for a radical new paradigm for treating addiction
Ars chats with author Maia Szalavitz about her book, Undoing Drugs
How each generation gets the drugs it deserves
LSD in the ’60s; ecstasy in the ’80s; ‘smart’ drugs today: how we get high reflects the desires and fears of our times
Russell Brand: my life without drugs
Russell Brand has not used drugs for 10 years. He has a job, a house, a cat, good friends. But temptation is never far away. He wants to help other addicts, but first he wants us to feel compassion for those affected
We monitor hundreds of publications, blogs, newsletters, and news sources in Drugs, including:
MIT Technology Review
Our in-depth reporting on innovation reveals and explains what’s really happening now to help you know what’s coming next. http://technologyreview.com/newsletters
The voice of 8 billion citizens.
This is the official Twitter account of ETH Zurich in English. Stay tuned for the latest news on research, technology and education. Deutscher Account: @eth
Learn from the world’s biggest thinkers.
The original online source for news, politics and entertainment | Find us on Instagram & TikTok: salonofficial | Subscribe to our newsletters linked in bio.
What is Refind?
Every day Refind picks the most relevant links from around the web for you. Picking only a handful of links means focusing on what’s relevant and useful. We favor timeless pieces—links with long shelf-lives, articles that are still relevant one month, one year, or even ten years from now. These lists of the best resources on any topic are the result of years of careful curation.
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets the most relevant links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, mark as read, read later, «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Which sources does Refind monitor on drugs?
We monitor hundreds of sources on drugs, including MIT Technology Review, GallupNews, ETH Zurich, Big Think, Salon, and many more.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to email@example.com
Who uses Refind?
200k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.